<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000597162">
  <TermName>obatoclax mesylate</TermName>
  <TermPronunciation>(oh-BA-toh-klax MEH-zih-layt)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of several types of cancer. It is a form of obatoclax, which blocks the activity of certain proteins needed for cells to live and may cause tumor cells to die. It is a type of apoptosis inducer.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000720961" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;obatoclax mesylate&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000720960" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;mesilato de obatoclax&quot;" language="es" id="_4"/>
  <SpanishTermName>mesilato de obatoclax</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de varios tipos de cáncer. Es una forma de obatoclax que bloquea la actividad de ciertas proteínas que las células necesitan para vivir y que puede destruir las células cancerosas. Es un tipo de inductor de la citoptosis.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2008-05-30</DateFirstPublished>
</GlossaryTerm>
